These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 35321550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The science of hope: an interview with Randy Jirtle.
    Jirtle RL.
    Epigenomics; 2022 Mar; 14(6):299-302. PubMed ID: 35264021
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The era of biomarkers and precision medicine in colorectal cancer: an interview with Ajay Goel.
    Goel A.
    Epigenomics; 2022 Mar; 14(6):345-349. PubMed ID: 35081730
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Understanding environmental epigenomics in autism spectrum disorder: an interview with Farah R Zahir.
    Zahir FR.
    Epigenomics; 2021 Sep; 13(17):1341-1345. PubMed ID: 34553604
    [Abstract] [Full Text] [Related]

  • 10. Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
    Fennell L, Dumenil T, Wockner L, Hartel G, Nones K, Bond C, Borowsky J, Liu C, McKeone D, Bowdler L, Montgomery G, Klein K, Hoffmann I, Patch AM, Kazakoff S, Pearson J, Waddell N, Wirapati P, Lochhead P, Imamura Y, Ogino S, Shao R, Tejpar S, Leggett B, Whitehall V.
    Cell Mol Gastroenterol Hepatol; 2019 Sep; 8(2):269-290. PubMed ID: 30954552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insights on exposure-induced disease susceptibility: an interview with Jaclyn Goodrich.
    Goodrich J.
    Epigenomics; 2022 Mar; 14(6):319-321. PubMed ID: 35259919
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epigenomic technologies: an interview with Jörg Tost.
    Tost J.
    Epigenomics; 2022 Mar; 14(6):359-363. PubMed ID: 35089083
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel.
    Goel A.
    Future Oncol; 2017 Dec; 13(28):2511-2514. PubMed ID: 29168653
    [Abstract] [Full Text] [Related]

  • 20. Risks and rewards of big-data in epigenomics research: an interview with Melanie Ehrlich.
    Ehrlich M.
    Epigenomics; 2022 Mar; 14(6):351-358. PubMed ID: 35255735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.